Drug Shortage Report for HIBERIX

Last updated on 2017-12-06 History
Report ID 29521
Drug Identification Number 02239200
Brand name HIBERIX
Common or Proper name Haemophilus influenzae type b (Hib) conjugate vaccine
Company Name GLAXOSMITHKLINE INC
Active Ingredient(s) HAEMOPHILUS INFLUENZAE TYPE B-PRP AND TETANUS TOXOID CONJUGATE
Strength(s) 10MCG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR
Packaging size 1's
ATC code J07AG
ATC description BACTERIAL VACCINES
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2017-11-16
Estimated end date 2017-12-07
Actual end date 2017-12-04
Shortage status Resolved
Updated date 2017-12-06
Company comments
Health Canada comments
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2017-12-06 French Compare
v5 2017-12-06 English Compare
v4 2017-12-01 French Compare
v3 2017-12-01 English Compare
v2 2017-11-17 French Compare
v1 2017-11-17 English Compare